{"id":"https://openalex.org/W4403516801","doi":"https://doi.org/10.1093/infdis/jiae511","title":"Vaccines for Global Health: Progress and Challenges","display_name":"Vaccines for Global Health: Progress and Challenges","publication_year":2024,"publication_date":"2024-10-16","ids":{"openalex":"https://openalex.org/W4403516801","doi":"https://doi.org/10.1093/infdis/jiae511","pmid":"https://pubmed.ncbi.nlm.nih.gov/39422259","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12308680"},"language":"en","primary_location":{"id":"doi:10.1093/infdis/jiae511","doi":"https://doi.org/10.1093/infdis/jiae511","is_oa":false,"landing_page_url":"https://doi.org/10.1093/infdis/jiae511","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12308680/pdf/jiae511.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076002884","display_name":"Jane M. Knisely","orcid":"https://orcid.org/0000-0003-0581-0742","observed_orcids":["https://orcid.org/0000-0003-0581-0742"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jane M Knisely","raw_affiliation_strings":["Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health , Rockville, Maryland ,"],"raw_orcid":"https://orcid.org/0000-0003-0581-0742","affiliations":[{"raw_affiliation_string":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health , Rockville, Maryland ,","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067972825","display_name":"Emily J. Erbelding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Erbelding","raw_affiliation_strings":["Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health , Rockville, Maryland ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health , Rockville, Maryland ,","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5076002884"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"],"apc_list":{"value":5001,"currency":"USD","value_usd":5001},"apc_paid":null,"fwci":3.7551,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.94194866,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"232","issue":"1","first_page":"25","last_page":"27"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.4713999927043915,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.4713999927043915,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13410","display_name":"Immune responses and vaccinations","score":0.37940001487731934,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.048500001430511475,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vaccines","display_name":"vaccines","score":0.5360000133514404},{"id":"https://openalex.org/keywords/global-health","display_name":"global health","score":0.7570000290870667},{"id":"https://openalex.org/keywords/vaccine-equity","display_name":"vaccine equity","score":0.6949999928474426},{"id":"https://openalex.org/keywords/covid-19-vaccines","display_name":"COVID-19 vaccines","score":0.8190000057220459},{"id":"https://openalex.org/keywords/vaccine-platforms","display_name":"vaccine platforms","score":0.6700000166893005},{"id":"https://openalex.org/keywords/adjuvants","display_name":"adjuvants","score":0.7820000052452087},{"id":"https://openalex.org/keywords/immunogen-design","display_name":"immunogen design","score":0.8479999899864197},{"id":"https://openalex.org/keywords/expanded-programme-on-immunization","display_name":"Expanded Programme on Immunization","score":0.921999990940094},{"id":"https://openalex.org/keywords/hpv-vaccination","display_name":"HPV vaccination","score":0.5440000295639038},{"id":"https://openalex.org/keywords/cervical-cancer-prevention","display_name":"cervical cancer prevention","score":0.621999979019165},{"id":"https://openalex.org/keywords/vaccine-hesitancy","display_name":"vaccine hesitancy","score":0.6150000095367432},{"id":"https://openalex.org/keywords/hiv-vaccine","display_name":"HIV vaccine","score":0.3700000047683716},{"id":"https://openalex.org/keywords/tuberculosis-vaccine","display_name":"tuberculosis vaccine","score":0.7889999747276306},{"id":"https://openalex.org/keywords/malaria-vaccine","display_name":"malaria vaccine","score":0.9639999866485596}],"concepts":[{"id":"https://openalex.org/C46578552","wikidata":"https://www.wikidata.org/wiki/Q2725393","display_name":"Global health","level":3,"score":0.5455405712127686},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5023128986358643},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4353669285774231},{"id":"https://openalex.org/C138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","level":2,"score":0.39848440885543823},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.3349313735961914},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09299823641777039}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/infdis/jiae511","doi":"https://doi.org/10.1093/infdis/jiae511","is_oa":false,"landing_page_url":"https://doi.org/10.1093/infdis/jiae511","pdf_url":null,"source":{"id":"https://openalex.org/S54542293","display_name":"The Journal of Infectious Diseases","issn_l":"0022-1899","issn":["0022-1899","1537-6613"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12308680","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12308680","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12308680/pdf/jiae511.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Infect Dis","raw_type":"Text"},{"id":"pmid:39422259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39422259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of infectious diseases","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:12308680","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12308680","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12308680/pdf/jiae511.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Infect Dis","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506},{"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities","score":0.8974000215530396},{"id":"https://metadata.un.org/sdg/17","display_name":"Partnerships for the goals","score":0.5217000246047974}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403516801.pdf","grobid_xml":"https://content.openalex.org/works/W4403516801.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W2982353502","https://openalex.org/W3034248695","https://openalex.org/W3138052084","https://openalex.org/W3187496430","https://openalex.org/W4290975583","https://openalex.org/W4291708333","https://openalex.org/W4299683584","https://openalex.org/W4379967316","https://openalex.org/W4394860061","https://openalex.org/W4394894573","https://openalex.org/W4395699463","https://openalex.org/W4396571207"],"related_works":["https://openalex.org/W4213447833","https://openalex.org/W4417495507","https://openalex.org/W3201547271","https://openalex.org/W3178592334","https://openalex.org/W4281784236","https://openalex.org/W4379471480","https://openalex.org/W4313904451","https://openalex.org/W4327950899","https://openalex.org/W4386144467","https://openalex.org/W4380423266"],"abstract_inverted_index":{"Vaccination":[0],"is":[1,154,190,295,348,443,470,621,672,764,895,925,946,1085,1161,1189,1238,1298,1343],"one":[2,349],"of":[3,34,65,75,111,121,150,176,182,234,241,273,350,358,389,420,452,475,485,527,554,571,612,635,683,772,778,792,836,872,933,938,943,970,1047,1057,1078,1091,1116,1129,1142,1197,1212,1250,1256,1275,1290,1331,1338,1358,1417,1441,1482,1500,1514],"the":[4,20,31,37,55,61,109,114,128,151,201,220,231,238,256,271,283,296,305,351,359,450,471,516,525,582,608,613,622,636,647,680,684,691,695,703,712,723,779,803,831,870,892,929,934,950,994,1041,1045,1055,1074,1213,1254,1272,1286,1303,1314,1327,1336,1339,1376,1418,1496,1511],"most":[5,202],"effective":[6,1010],"public":[7],"health":[8,1498],"tools":[9],"ever":[10,902],"developed,":[11],"having":[12],"saved":[13],"an":[14,96,719,1221],"estimated":[15],"154":[16],"million":[17,1063],"lives":[18],"in":[19,71,113,147,163,206,224,253,270,277,317,366,401,437,480,531,534,592,646,656,711,744,783,787,802,814,820,855,864,912,915,920,959,977,1030,1093,1104,1306,1360,1389,1449,1471],"past":[21,306],"50":[22,307],"years":[23,308,478,484],"alone":[24],"[1].":[25,309,332],"Vaccine":[26,1459,1485],"technologies":[27],"have":[28,169,246,266,403,1014,1096,1150,1309,1363],"evolved":[29],"from":[30,107,203,690,794,986],"crude":[32],"practice":[33],"variolation":[35],"to":[36,99,104,117,214,230,248,250,300,313,406,498,562,581,638,686,694,725,735,860,878,883,964,993,1005,1012,1040,1156,1245,1271,1300,1326,1368,1381,1424,1435,1438,1493],"cutting-edge":[38],"immunogen":[39,80],"design,":[40,81,1112],"vaccine":[41,76,83,87,125,141,165,225,254,336,367,381,447,499,590,654,893,908,988,999,1084,1111,1154,1187,1316,1467,1502],"platforms,":[42,84],"adjuvant":[43],"science,":[44,368],"and":[45,47,63,85,106,119,138,143,237,263,279,326,347,376,378,391,398,423,429,433,457,488,509,538,550,569,574,642,728,732,785,798,829,853,866,886,888,923,954,983,1002,1008,1027,1033,1071,1119,1122,1173,1195,1230,1258,1264,1288,1318,1329,1355,1394,1414,1420,1432,1457,1478,1491,1516],"preclinical":[46],"clinical":[48,431,598,662,750,799,1233,1320],"testing":[49,1196,1330],"paradigms":[50],"that":[51,153,445,624,1176,1200,1292,1302,1323,1362],"exist":[52],"today.":[53],"During":[54,219],"coronavirus":[56],"disease":[57,800,880,914],"2019":[58],"(COVID-19)":[59],"pandemic,":[60,222,1341],"development":[62,88,142,1328,1354,1440],"implementation":[64,1259],"these":[66,465,514],"approaches":[67,1175],"were":[68,227,1324],"accelerated,":[69],"ushering":[70],"a":[72,148,339,673,773,845,916,975,1087,1344],"new":[73,369,458,558,1064],"era":[74],"science":[77],"where":[78],"structure-based":[79],"plug-and-play":[82],"historic":[86],"partnerships":[89],"took":[90],"center":[91],"stage.":[92],"COVID-19":[93,158,221,1332,1340,1442],"also":[94,159,617,1015,1208,1352,1399],"offered":[95],"unprecedented":[97,239],"opportunity":[98],"understand":[100],"protective":[101,1204],"immune":[102,115,555,572,1117,1214],"responses":[103],"infection":[105,416,796],"vaccination,":[108],"role":[110],"imprinting":[112],"response":[116,341],"vaccines,":[118,585,1426],"correlates":[120],"protection":[122,793,850,944,971,1294],"for":[123,172,194,320,335,371,373,411,427,464,524,602,666,675,754,761,768,827,948,1051,1110,1225,1349,1353,1378,1391,1454,1462],"different":[124,564],"platforms":[126,236],"utilizing":[127],"same":[129],"immunogen.":[130],"The":[131,310,333,840,905,1126,1185],"pandemic":[132,340],"revealed":[133],"that,":[134],"with":[135,174,962,1060,1138],"enough":[136],"funding":[137],"political":[139,1430],"will,":[140],"approval":[144],"can":[145,1177,1201],"occur":[146],"fraction":[149],"time":[152],"usually":[155],"required.":[156],"However,":[157],"laid":[160],"bare":[161],"inequities":[162,168,223],"global":[164,242,261,380,1319,1345,1497],"access.":[166],"These":[167],"been":[170,343,903],"evident":[171],"decades":[173],"distribution":[175,226],"other":[177,879,1210,1311],"vaccines.":[178,1443],"For":[179],"example,":[180],"elimination":[181],"cervical":[183,204],"cancer":[184,205],"through":[185,282,1227],"human":[186],"papillomavirus":[187],"(HPV)":[188],"vaccination":[189,409,1174,1198],"now":[191,1190],"within":[192],"reach":[193],"high-income":[195,438],"countries,":[196],"while":[197,1207],"women":[198],"who":[199],"suffer":[200],"low-income":[207],"settings":[208],"had":[209,1365],"virtually":[210],"no":[211],"country-level":[212],"access":[213,1390],"HPV":[215],"vaccines":[216,276,319,372,523,541,559,677,874,1095,1308,1333,1359,1385],"until":[217],"recently.":[218],"amplified":[228],"due":[229,882],"added":[232],"expense":[233],"novel":[235],"intensity":[240],"demand.":[243],"While":[244,869,1044],"we":[245],"work":[247,1507],"do":[249],"achieve":[251,736],"equity":[252,337,1388],"access,":[255,1350],"World":[257],"Health":[258],"Organization":[259],"(WHO),":[260],"donors,":[262],"philanthropic":[264],"organizations":[265],"made":[267,1305],"amazing":[268],"strides":[269],"delivery":[272],"routine":[274],"childhood":[275],"low-":[278],"middle-income":[280],"countries":[281],"Expanded":[284],"Programme":[285],"on":[286,1153,1192],"Immunization":[287],"(EPI).":[288],"A":[289,967,1083],"recent":[290,446,774,1127],"analysis":[291,945],"suggests":[292],"this":[293,620,698,939,1266,1366],"program":[294],"single":[297],"greatest":[298],"contributor":[299],"improved":[301,379],"infant":[302],"survival":[303],"over":[304],"EPI":[311],"aims":[312],"make":[314],"further":[315],"progress":[316,821],"providing":[318,1282],"both":[321,374,412,949,1392],"children":[322,375,481,532,786],"(HPV,":[323],"malaria,":[324,546],"meningitis)":[325],"adults":[327,784,867,922],"(COVID-19,":[328],"respiratory":[329],"syncytial":[330],"virus)":[331],"need":[334,426,674],"during":[338,640,1404],"has":[342,518,824,901,1053],"recognized":[344],"as":[345,356,619,974,1371],"urgent":[346],"critical":[352,1088,1325,1401],"elements":[353],"under":[354,482],"negotiation":[355],"part":[357],"Pandemic":[360],"Accord":[361],"[2].":[362],"Despite":[363,513],"dramatic":[364],"advances":[365,460],"approvals":[370,448],"adults,":[377],"coverage,":[382],"several":[383,1231],"infectious":[384,473,833,1079],"diseases":[385],"remain":[386],"top":[387],"causes":[388,625],"death":[390,854],"disability.":[392],"Human":[393],"immunodeficiency":[394],"virus":[395],"(HIV),":[396],"tuberculosis,":[397],"malaria":[399,530,584,614,762,795],"[3],":[400],"particular,":[402],"proven":[404],"themselves":[405,1218],"be":[407,1006,1243,1262],"challenging":[408,466],"targets":[410],"scientific":[413],"(eg,":[414,425],"complex":[415,502,1114],"cycles,":[417],"high":[418,727,790],"degree":[419],"pathogen":[421,644],"variability)":[422],"nonscientific":[424],"large":[428,643,887,1232],"lengthy":[430,889],"trials":[432,455,818,989,1141,1234,1280,1321],"limited":[434,552,633,884],"potential":[435],"market":[436],"countries)":[439],"reasons.":[440],"Nevertheless,":[441,1278],"there":[442,586,671,924,1342,1445],"hope":[444],"(malaria),":[449],"launch":[451,932],"long-awaited":[453],"pivotal":[454,890],"(tuberculosis),":[456],"technological":[459],"may":[461,707,811,1219,1386,1428,1488],"identify":[462],"solutions":[463],"killer":[467],"pathogens.":[468],"Malaria":[469,493],"leading":[472,832,1076],"cause":[474,835,1077],"disability-adjusted":[476],"life":[477,565],"(DALYs)":[479],"5":[483],"age":[486],"[4]":[487],"disproportionately":[489],"impacts":[490],"sub-Saharan":[491,1372],"Africa.":[492],"parasites":[494],"pose":[495,1220],"significant":[496],"obstacles":[497],"development,":[500,599,663],"including":[501,600,664,752,1113,1313],"lifecycles,":[503],"diverse":[504],"strains,":[505,1252],"polymorphic":[506],"invasion":[507,631],"molecules,":[508],"redundant":[510,630],"biological":[511],"pathways.":[512],"challenges,":[515],"WHO":[517],"recently":[519],"recommended":[520],"2":[521,597,661,665,749,753,776,953,957],"related":[522],"prevention":[526,763,1223],"Plasmodium":[528,603],"falciparum":[529],"living":[533,1059],"endemic":[535,1393],"areas:":[536],"RTS,S/AS01":[537],"R21-Matrix-M.":[539],"Both":[540],"target":[542],"preerythrocyte":[543,589],"(sporozoite/liver)":[544],"stage":[545,611,623,682],"require":[547,718,1429],"multiple":[548],"doses,":[549],"provide":[551,1246,1293,1400,1489],"durability":[553,570],"response;":[556],"therefore,":[557],"are":[560,587,616,651,740,819,1021,1066,1165,1181,1235,1281,1446],"needed":[561,1423],"address":[563],"stages,":[566],"improve":[567],"efficacy":[568,911,1105],"response,":[573],"protect":[575],"against":[576,851],"non-falciparum":[577],"species.":[578],"In":[579,991],"addition":[580,992],"approved":[583],"15":[588,652],"candidates":[591,655,716,743,1000,1029,1099,1130],"active":[593,657],"phase":[594,658,745,748,775,917,935,952,956,1017,1031],"1":[595,601,659,746,1032],"or":[596,660,747,1134],"vivax":[604,668,756],"[5].":[605,669,757],"Vaccines":[606],"targeting":[607,679],"merozoite":[609],"(blood)":[610],"parasite":[615,685,688],"desirable,":[618],"disease;":[626],"however,":[627],"challenges":[628,1109,1260],"include":[629,1408],"pathways,":[632],"exposure":[634],"merozoites":[637],"antibodies":[639,766,1133,1145,1291],"infection,":[641],"burden":[645],"blood":[648],"[6].":[649,738],"There":[650,739,1020],"blood-stage":[653],"P.":[667,755],"Finally,":[670,1296],"transmission-blocking":[676],"(TBVs)":[678],"mosquito/sexual":[681],"interrupt":[687],"transmission":[689],"infected":[692,1067],"person":[693],"vector.":[696],"As":[697],"approach":[699,810,1267],"confers":[700],"benefit":[701],"at":[702],"population":[704],"level":[705,1287],"but":[706,857,1100,1351],"not":[708,1162,1182,1347,1364],"prevent":[709,861,965],"illness":[710],"vaccinated":[713],"person,":[714],"TBV":[715,742],"will":[717,1242,1431],"immaculate":[720],"safety":[721],"profile,":[722],"ability":[724],"elicit":[726],"durable":[729],"antibody":[730,781],"levels,":[731],"widespread":[733],"adoption":[734],"success":[737],"9":[741,1022],"trials,":[751,891,979,1035],"Another":[758],"promising":[759,1447],"tool":[760],"monoclonal":[765,780],"used":[767],"passive":[769,1228],"immunization.":[770],"Results":[771],"trial":[777,919,937,958],"L9LS":[782],"Mali":[788],"demonstrated":[789,909],"levels":[791],"(70%)":[797],"(77%)":[801],"high-dose":[804],"group":[805],"6":[806],"months":[807],"postinjection.":[808],"This":[809,1160,1506],"prove":[812],"favorable":[813],"certain":[815],"populations;":[816],"additional":[817,1023],"[7].":[822],"Tuberculosis":[823],"afflicted":[825],"humanity":[826],"millennia":[828],"remains":[830,1073],"disease-related":[834],"DALYs":[837,1081],"globally":[838],"[3].":[839],"BCG":[841,963],"vaccine,":[842,996],"more":[843,897,1009,1037],"than":[844,899],"century":[846],"old,":[847],"offers":[848],"some":[849],"tuberculosis":[852,863,873,987],"children,":[856],"does":[858],"little":[859],"pulmonary":[862],"adolescents":[865,960],"[8].":[868],"field":[871,1188],"moves":[875],"slowly":[876],"relative":[877],"areas":[881],"resources":[885,1433],"pipeline":[894,1042],"currently":[896],"robust":[898,1038],"it":[900,1297],"[9].":[904,1043],"M72":[906,951,995],"AS01E":[907],"49.7%":[910],"preventing":[913],"2b":[918],"tuberculosis-infected":[921],"much":[926],"excitement":[927],"surrounding":[928],"March":[930],"2024":[931],"3":[936,1018],"candidate":[940],"[10].":[941],"Correlates":[942],"underway":[947],"another":[955],"revaccinated":[961],"infection.":[966],"validated":[968],"correlate":[969],"could":[972,1261],"serve":[973],"biomarker":[976],"future":[978,1405],"thus":[980],"facilitating":[981],"smaller":[982],"faster":[984],"answers":[985],"[11].":[990],"live":[997],"attenuated":[998],"VPM1002":[1001],"MTBVAC,":[1003],"designed":[1004],"safer":[1007],"alternatives":[1011],"BCG,":[1013],"entered":[1016],"trials.":[1019,1106],"protein,":[1024],"viral":[1025],"vector,":[1026],"mRNA-based":[1028],"2a":[1034],"bringing":[1036],"diversity":[1039,1124],"availability":[1046],"antiretroviral":[1048],"therapy":[1049],"(ART)":[1050],"HIV":[1052,1072,1094,1107,1186,1226,1307],"revolutionized":[1054],"prognosis":[1056],"those":[1058,1436],"HIV,":[1061],"1.3":[1062],"people":[1065],"each":[1068],"year":[1069],"[12]":[1070],"third":[1075],"disease-associated":[1080],"[4].":[1082],"still":[1086],"goal.":[1089],"Decades":[1090],"investment":[1092],"produced":[1097,1169],"many":[1098],"only":[1101,1166],"disappointing":[1102],"results":[1103],"presents":[1108],"mechanisms":[1115],"evasion":[1118],"vast":[1120],"sequence":[1121],"antigen":[1123],"[13].":[1125,1216,1295],"failures":[1128],"stimulating":[1131],"nonneutralizing":[1132],"T-cell":[1135],"responses,":[1136,1206],"combined":[1137],"encouraging":[1139],"proof-of-concept":[1140],"broadly":[1143],"neutralizing":[1144],"(bnAbs)":[1146],"administered":[1147],"prophylactically":[1148],"[14]":[1149],"refocused":[1151],"attention":[1152],"strategies":[1155,1199],"produce":[1157,1382,1425],"bnAbs":[1158,1164,1217,1241],"[15].":[1159],"straightforward:":[1163],"very":[1167],"rarely":[1168],"by":[1170,1510],"HIV-infected":[1171],"individuals":[1172],"effectively":[1178,1202],"induce":[1179,1203],"them":[1180],"yet":[1183],"clear.":[1184],"focusing":[1191],"iterative":[1193],"design":[1194,1317],"bnAb":[1205,1279],"engaging":[1209],"arms":[1211],"system":[1215],"alternative":[1222],"strategy":[1224],"immunization,":[1229],"ongoing.":[1236],"It":[1237,1397],"unclear":[1239],"whether":[1240,1253,1265],"able":[1244],"sufficiently":[1247],"broad":[1248],"coverage":[1249],"ever-evolving":[1251],"cost":[1255],"goods":[1257],"overcome,":[1263],"would":[1268,1398],"add":[1269],"value":[1270],"existing":[1273],"armamentarium":[1274],"long-acting":[1276],"ART.":[1277],"important":[1283,1299],"information":[1284],"about":[1285],"characteristics":[1289],"note":[1301],"investments":[1304],"borne":[1310],"fruits,":[1312],"structure-guided":[1315],"networks":[1322],"[16].":[1334],"On":[1335],"heels":[1337],"outcry":[1346],"just":[1348],"local":[1356],"production":[1357],"regions":[1361],"capacity":[1367,1377,1403],"date,":[1369],"such":[1370],"Africa":[1373,1450],"[17].":[1374],"Developing":[1375],"every":[1379],"region":[1380],"their":[1383],"own":[1384],"promote":[1387],"outbreak-related":[1395],"diseases.":[1396],"surge":[1402],"pandemics.":[1406],"Obstacles":[1407],"sustainable":[1409],"financing,":[1410],"intellectual":[1411],"property":[1412],"concerns,":[1413],"consistent":[1415],"maintenance":[1416],"facilities":[1419],"technical":[1421],"workforce":[1422],"which":[1427,1487],"comparable":[1434],"applied":[1437],"rapid":[1439],"Globally,":[1444],"developments":[1448],"(African":[1451],"Union/Africa":[1452],"Centers":[1453],"Disease":[1455],"Control":[1456],"Prevention's":[1458],"Manufacturing":[1460],"Framework":[1461],"Action":[1463],"[18],":[1464],"WHO's":[1465],"mRNA":[1466],"technology":[1468],"transfer":[1469],"hub":[1470],"South":[1472,1474],"Africa),":[1473],"America":[1475],"(Instituto":[1476],"Butantan),":[1477],"Asia":[1479],"(Serum":[1480],"Institute":[1481,1513],"India,":[1483],"International":[1484],"Institute),":[1486],"roadmaps":[1490],"infrastructure":[1492],"move":[1494],"toward":[1495],"goal":[1499],"distributed":[1501],"manufacturing.":[1503],"Financial":[1504],"support.":[1505],"was":[1508],"supported":[1509],"National":[1512],"Allergy":[1515],"Infectious":[1517],"Diseases.":[1518]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-10-18T00:00:00"}